Press Release – Science Media Centre
New Zealands medicines regulator has asked for more information from Janssen, with countries putting the companys Covid-19 vaccine on hold due to rare blood clot concerns. The Janssen vaccine was next in line to be approved for use in New …
New Zealand’s medicines regulator has asked for more information from Janssen, with countries putting the company’s Covid-19 vaccine on hold due to rare blood clot concerns.
The Janssen vaccine was next in line to be approved for use in New Zealand, but over the past few days
The SMC asked experts to comment.